PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,858 | -7.9% | 4,526 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $150,743 | +6.5% | 3,762 | +8.5% | 0.01% | 0.0% |
| Q1 2023 | $141,529 | +9.4% | 3,468 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $129,426 | -29.7% | 3,468 | 0.0% | 0.01% | -37.5% |
| Q3 2022 | $184,000 | -8.9% | 3,468 | 0.0% | 0.01% | -11.1% |
| Q2 2022 | $202,000 | -23.8% | 3,468 | 0.0% | 0.01% | -10.0% |
| Q1 2022 | $265,000 | +26.8% | 3,468 | 0.0% | 0.01% | +42.9% |
| Q4 2021 | $209,000 | +7.7% | 3,468 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $194,000 | -7.6% | 3,468 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $210,000 | -13.6% | 3,468 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $243,000 | +11.5% | 3,468 | -4.7% | 0.01% | -10.0% |
| Q4 2020 | $218,000 | -0.5% | 3,640 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $219,000 | +14.7% | 3,640 | 0.0% | 0.01% | +11.1% |
| Q2 2020 | $191,000 | +56.6% | 3,640 | 0.0% | 0.01% | +28.6% |
| Q1 2020 | $122,000 | -21.8% | 3,640 | +5.5% | 0.01% | 0.0% |
| Q4 2019 | $156,000 | +19.1% | 3,449 | 0.0% | 0.01% | +16.7% |
| Q3 2019 | $131,000 | -12.7% | 3,449 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $150,000 | +14.5% | 3,449 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $131,000 | -11.5% | 3,449 | 0.0% | 0.01% | -25.0% |
| Q4 2018 | $148,000 | -12.9% | 3,449 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $170,000 | +53.2% | 3,449 | 0.0% | 0.01% | +60.0% |
| Q2 2018 | $111,000 | +3.7% | 3,449 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $107,000 | -31.8% | 3,449 | 0.0% | 0.01% | -28.6% |
| Q4 2017 | $157,000 | +19.8% | 3,449 | 0.0% | 0.01% | +16.7% |
| Q3 2017 | $131,000 | -20.6% | 3,449 | 0.0% | 0.01% | -25.0% |
| Q2 2017 | $165,000 | +14.6% | 3,449 | +9.6% | 0.01% | +14.3% |
| Q1 2017 | $144,000 | -33.3% | 3,147 | +11.9% | 0.01% | -53.3% |
| Q4 2015 | $216,000 | -23.9% | 2,812 | -12.0% | 0.02% | -21.1% |
| Q1 2015 | $284,000 | +0.4% | 3,195 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $283,000 | -8.7% | 3,195 | 0.0% | 0.02% | -13.6% |
| Q3 2014 | $310,000 | +5.8% | 3,195 | 0.0% | 0.02% | +4.8% |
| Q2 2014 | $293,000 | – | 3,195 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |